ModAstera ist eine No-Code-KI-Entwicklungsplattform für medizinische Anwendungen. Sie automatisiert die prädiktive Modellierung für Patientenrisiken und -ergebnisse, bietet KI-gestützte Datenannotation und Ein-Klick-Bereitstellung, um die Entwicklungszeit und -kosten für Health-Tech-Innovatoren erheblich zu reduzieren.
Robovision ist eine End-to-End, No-Code Computer Vision KI-Plattform für industrielle Anwendungen. Sie befähigt Unternehmen in der Landwirtschaft, Fertigung und im Gesundheitswesen, KI-Modelle zu erstellen, bereitzustellen und kontinuierlich zu optimieren und so komplexe Automatisierungsherausforderungen in operative Vorteile zu verwandeln, ohne tiefgreifende Programmierkenntnisse zu erfordern.
ModAstera ist eine No-Code-KI-Entwicklungsplattform für medizinische Anwendungen. Sie automatisiert die prädiktive Modellierung für Patientenrisiken und -ergebnisse, bietet KI-gestützte Datenannotation und Ein-Klick-Bereitstellung, um die Entwicklungszeit und -kosten für Health-Tech-Innovatoren erheblich zu reduzieren.
Robovision ist eine End-to-End, No-Code Computer Vision KI-Plattform für industrielle Anwendungen. Sie befähigt Unternehmen in der Landwirtschaft, Fertigung und im Gesundheitswesen, KI-Modelle zu erstellen, bereitzustellen und kontinuierlich zu optimieren und so komplexe Automatisierungsherausforderungen in operative Vorteile zu verwandeln, ohne tiefgreifende Programmierkenntnisse zu erfordern.
| Feature | ModAstera | Robovision |
|---|---|---|
| Hauptkategorie | Maschinelles Lernen | No-Code-Plattform |
| Hinzugefügt | 2025-10-22 | 2025-08-14 |
| Preismodell | Freemium | Kostenpflichtig |
| Offizielle Website | www.modastera.com | robovision.ai |
| Produkttyp | Website | Website |
| Performance data | ||
| Nutzerbewertung | Nicht verifiziert | Nicht verifiziert |
| Kommentare | 0 | 0 |
| Monatliche Besuche | 250 | 11.6K |
| Monatliches Wachstum | -68.4% | -25.9% |
| Favoriten | 85 | 118 |
| Details | Details ansehen | Details ansehen |
Compare ModAstera and Robovision by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
In the ModAstera vs Robovision monthly traffic comparison, ModAstera currently shows 250 visits and Robovision shows 11.6K; Robovision has about 46.3 times the visible traffic of ModAstera, an absolute difference of about 11.3K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇧🇪Belgium | 32.96% | 3.8K |
| 🇮🇳India | 25.6% | 3K |
| 🇻🇳Vietnam | 17.92% | 2.1K |
| 🇺🇸United States | 13.97% | 1.6K |
| 🇩🇪Germany | 9.55% | 1.1K |
This in-depth ModAstera vs Robovision comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. ModAstera is primarily listed under “Maschinelles Lernen”, while Robovision is primarily listed under “No-Code-Plattform”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (ModAstera: Maschinelles Lernen; Robovision: No-Code-Plattform); Pricing (ModAstera: Freemium; Robovision: Paid); Monthly visits (ModAstera: 250; Robovision: 11.6K); Monthly growth (ModAstera: -68.4%; Robovision: -25.9%); Favorites (ModAstera: 85; Robovision: 118). These facts are more useful for selection than brand visibility alone.
In the ModAstera vs Robovision monthly traffic comparison, ModAstera currently shows 250 visits and Robovision shows 11.6K; Robovision has about 46.3 times the visible traffic of ModAstera, an absolute difference of about 11.3K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
If public market visibility is an important first-pass criterion, investigate Robovision first. The final choice should still follow taxonomy, use case, and a real trial because higher traffic does not prove broader capabilities or better workflow fit.
ModAstera and Robovision currently overlap in shared categories: No-Code-Plattform; shared tags: Datenannotation, KI im Gesundheitswesen, maschinelles Lernen und No-Code. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
ModAstera's unique categories/tags are Maschinelles Lernen, Medizinische KI, KI-Entwicklung, klinische Forschung, Gesundheitstechnologie, HIPAA-konform, MAEA und Prädiktive Modellierung; Robovision's are Computer Vision, Automatisierung, Landwirtschafts-KI, Industrieautomation, Fertigungs-KI, Modellbereitstellung und Qualitätskontrolle. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
ModAstera has no verified rating, 0 comments, 85 favorites, and 88 likes；Robovision has no verified rating, 0 comments, 118 favorites, and 125 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Put ModAstera on the priority trial list when the task aligns with “Maschinelles Lernen” and especially Maschinelles Lernen, Medizinische KI, KI-Entwicklung, klinische Forschung, Gesundheitstechnologie und HIPAA-konform, or the users include Bioinformatiker, Kliniker, Datenwissenschaftler und IT-Manager im Gesundheitswesen. This follows recorded positioning and does not imply unlisted capabilities are absent.
ModAstera also currently records: pricing is freemium, product type is website, 250 verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
Put Robovision on the priority trial list when the task aligns with “No-Code-Plattform” and especially Computer Vision, Automatisierung, Landwirtschafts-KI, Industrieautomation, Fertigungs-KI und Modellbereitstellung. This follows recorded positioning and does not imply unlisted capabilities are absent.
Robovision also currently records: pricing is paid, product type is website, 11.6K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in ModAstera and Robovision, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
